Literature DB >> 20176809

PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling.

Peter Noy1, Hannah Williams, Anyaporn Sawasdichai, Kevin Gaston, Padma-Sheela Jayaraman.   

Abstract

The proline-rich homeodomain protein (PRH) plays multiple roles in the control of gene expression during embryonic development and in the adult. Vascular endothelial growth factor (VEGF) is a mitogen that stimulates cell proliferation and survival via cell surface receptors including VEGFR-1 and VEGFR-2. VEGF signaling is of critical importance in angiogenesis and hematopoiesis and is elevated in many tumors. Here we show that PRH binds directly to the promoter regions of the Vegf, Vegfr-1, and Vegfr-2 genes and that in each case PRH represses transcription. We demonstrate that overexpression or knockdown of PRH directly impinges on the survival of both leukemic and tumor cells and that the modulation of VEGF and VEGF receptor signaling by PRH mediates these effects. Our findings demonstrate that PRH is a key regulator of the VEGF signaling pathway and describe a mechanism whereby PRH plays an important role in tumorigenesis and leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20176809      PMCID: PMC2863580          DOI: 10.1128/MCB.01511-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  79 in total

1.  Transforming growth factor-beta 1-mediated inhibition of the flk-1/KDR gene is mediated by a 5'-untranslated region palindromic GATA site.

Authors:  T Minami; R D Rosenberg; W C Aird
Journal:  J Biol Chem       Date:  2000-11-29       Impact factor: 5.157

2.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

3.  Vascular endothelial growth factor receptor-2: counter-regulation by the transcription factors, TFII-I and TFII-IRD1.

Authors:  Tanisha A Jackson; Harry E Taylor; Deva Sharma; Stephen Desiderio; Sonye K Danoff
Journal:  J Biol Chem       Date:  2005-06-07       Impact factor: 5.157

Review 4.  Oxygen sensors and angiogenesis.

Authors:  Patrick H Maxwell; Peter J Ratcliffe
Journal:  Semin Cell Dev Biol       Date:  2002-02       Impact factor: 7.727

5.  Nuclear protein interactions with the human KDR/flk-1 promoter in vivo. Regulation of Sp1 binding is associated with cell type-specific expression.

Authors:  C Patterson; Y Wu; M E Lee; J D DeVault; M S Runge; E Haber
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

6.  Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin.

Authors:  M A Goldberg; T J Schneider
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

7.  VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.

Authors:  Hans-Peter Gerber; Ajay K Malik; Gregg P Solar; Daniel Sherman; Xiao Huan Liang; Gloria Meng; Kyu Hong; James C Marsters; Napoleone Ferrara
Journal:  Nature       Date:  2002-06-27       Impact factor: 49.962

8.  BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.

Authors:  Matthias Mayerhofer; Peter Valent; Wolfgang R Sperr; James D Griffin; Christian Sillaber
Journal:  Blood       Date:  2002-07-18       Impact factor: 22.113

Review 9.  Human myeloid leukemia cell lines: a review.

Authors:  H P Koeffler; D W Golde
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

10.  Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.

Authors:  A S Chan; S Y Leung; M P Wong; S T Yuen; N Cheung; Y W Fan; L P Chung
Journal:  Am J Surg Pathol       Date:  1998-07       Impact factor: 6.394

View more
  22 in total

1.  Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex.

Authors:  V Marfil; M Blazquez; F Serrano; J V Castell; R Bort
Journal:  Oncogene       Date:  2014-09-15       Impact factor: 9.867

2.  Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.

Authors:  Victoria Stepanova; Padma-Sheela Jayaraman; Sergei V Zaitsev; Tatiana Lebedeva; Khalil Bdeir; Rachael Kershaw; Kelci R Holman; Yelena V Parfyonova; Ekaterina V Semina; Irina B Beloglazova; Vsevolod A Tkachuk; Douglas B Cines
Journal:  J Biol Chem       Date:  2016-05-04       Impact factor: 5.157

3.  The tumor suppressor HHEX inhibits axon growth when prematurely expressed in developing central nervous system neurons.

Authors:  Matthew T Simpson; Ishwariya Venkatesh; Ben L Callif; Laura K Thiel; Denise M Coley; Kristen N Winsor; Zimei Wang; Audra A Kramer; Jessica K Lerch; Murray G Blackmore
Journal:  Mol Cell Neurosci       Date:  2015-08-23       Impact factor: 4.314

4.  Novel mechanisms of resistance to vemurafenib in melanoma - V600E B-Raf reversion and switching VEGF-A splice isoform expression.

Authors:  Nicholas Beazley-Long; Kevin Gaston; Steven J Harper; Antonio Orlando; David O Bates
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

5.  Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels.

Authors:  Serdar Bozdag; Aiguo Li; Gregory Riddick; Yuri Kotliarov; Mehmet Baysan; Fabio M Iwamoto; Margaret C Cam; Svetlana Kotliarova; Howard A Fine
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

6.  Dasatinib inhibits leukaemic cell survival by decreasing PRH/Hhex phosphorylation resulting in increased repression of VEGF signalling genes.

Authors:  Peter Noy; Kevin Gaston; Padma-Sheela Jayaraman
Journal:  Leuk Res       Date:  2012-08-05       Impact factor: 3.156

7.  DNA compaction by the higher-order assembly of PRH/Hex homeodomain protein oligomers.

Authors:  Abdenour Soufi; Anyaporn Sawasdichai; Anshuman Shukla; Peter Noy; Tim Dafforn; Corinne Smith; Padma-Sheela Jayaraman; Kevin Gaston
Journal:  Nucleic Acids Res       Date:  2010-07-31       Impact factor: 16.971

8.  The proline rich homeodomain protein PRH/Hhex forms stable oligomers that are highly resistant to denaturation.

Authors:  Anshuman Shukla; Nicholas M Burton; Padma-Sheela Jayaraman; Kevin Gaston
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

9.  Trisomy 8 Acute Myeloid Leukemia Analysis Reveals New Insights of DNA Methylome with Identification of HHEX as Potential Diagnostic Marker.

Authors:  Marwa H Saied; Jacek Marzec; Sabah Khalid; Paul Smith; Gael Molloy; Bryan D Young
Journal:  Biomark Cancer       Date:  2015-01-29

10.  Protein kinase CK2 inactivates PRH/Hhex using multiple mechanisms to de-repress VEGF-signalling genes and promote cell survival.

Authors:  Peter Noy; Anyaporn Sawasdichai; Padma-Sheela Jayaraman; Kevin Gaston
Journal:  Nucleic Acids Res       Date:  2012-07-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.